News & Events

Virtual Collaboration Platforms Are a Valuable Marketing Tool for Life Science Companies

In today’s fast-paced world, it can be hard to schedule in-person meetings with stakeholders. Yet medical companies face more pressure than ever to connect with stakeholders, or risk missing out on valuable networking opportunities.

Virtual collaboration platforms have emerged to help fill this gap. Savvy marketers can now use modern technology to meet stakeholders with greater convenience and ease. In turn, stakeholders have greater opportunities to share valuable insights about their patients and communities. With virtual collaboration platforms, marketers and stakeholders can engage with one another and work as a team.

If you’re thinking about making the shift toward a virtual platform, consider these advantages:

Online Platforms Allow Users to Get Input Fast
Live meetings and conferences are costly and time-consuming, and even if meeting attendees are willing to travel, scheduling a conference can be a significant logistic challenge.
Conferences often take months of planning, and sudden emergencies can throw a wrench into even the most carefully scheduled event. Collaboration platforms cut through the red tape, allowing users to share thoughts and opinions quickly. Questions can be posted instantly and are often answered within hours. In just a few days, you can collect all the essential stakeholder information you need.

Don’t forget, virtual platforms are available 24/7. That means you can log in at any time, day or night. With virtual platforms, there’s no need to play phone-tag or send a series of follow-up emails. Instead, it’s easy to double-check a critical piece of information simply by logging in.

Online Platforms Help Eliminate Logistic Roadblocks
Collaboration platforms also allow users to break into groups to discuss specialized topics. With virtual collaboration platforms, discussions and presentations become far more flexible. Extra attendees are hardly ever a problem in virtual platforms, where there is “unlimited seating.”

Conferences and seminars can also restrict discussion by limiting the number of topics and sessions. With in-person meetings, both time and space can be limited. As a result, attendees are often left to choose between a handful of lectures on a selected range of topics. In contrast, virtual collaboration platforms allow users to benefit from individual sessions. This customized content enables users to confer on topics that spark their interest, and bring their opinions to the forefront.

Virtual platforms can offer the best of both worlds. Online discussions are dynamic and can take place in real time, but can also be prepared well in advance, allowing users to share insights after an in-person conference or a new market launch. Discussion leaders don’t have to scramble to share the same set of documents with dozens of contacts. Instead, users can simply log in to one central area to view documents, share ideas, and make connections.

Online Collaboration Platforms Allow User Anonymity
Offline collaborations are sometimes hampered by the in-person setting. No matter how confident your colleagues are of their expertise, they may hesitate to offer criticism or express doubts when they’re sitting in the middle of a large group. Biases and groupthink can also flourish inside crowded conference rooms.

On the other hand, online discussion boards offer a sense of anonymity. They help encourage honest critiques and unbiased responses. Authentic reactions can establish better-quality discussions and more accurate data.

Because there is no physical interaction, the identity of the participants can remain undisclosed. Marketers can also observe online discussions in a private setting. Since participants know they’re operating in an independent online environment, they may feel comfortable speaking more freely among themselves.

Online Collaboration Platforms Are Convenient for Today’s Users
No longer do participants and advisors have to travel to a medical conference from every corner of the globe. Instead, attendees can log in from the comfort of their office, practice, or even their favorite coffee shop. Participants can work around their personal and professional responsibilities, joining discussions whenever they’re available.

Cutting down on business travel helps reduce costs and eliminate wasted time. Attendees can use virtual meeting spaces to make the most of their limited free time. Without the need to travel long distances, attendees can spend more time networking, joining discussions, and sharing valuable data. In turn, medical marketers have more significant opportunities to connect with healthcare providers.

Will Collaboration Platforms Completely Replace Live Meetings?
Even the best virtual collaboration platforms can never fully replace live meetings. Building personal relationships is an essential part of collaboration, and face-to-face meetings are still the best way to forge new connections. A blend of live meetings and virtual collaboration can help your organization cut costs and maximize the efficiency of your marketing efforts.

Virtual collaboration platforms offer a more efficient and less expensive alternative to live meetings. The anonymity provided by these platforms is another significant advantage for marketing companies who want a fast, discreet method for connection with stakeholders and gathering data. Customizable content available through virtual collaboration platforms also allows users to share their thoughts in a unique, flexible setting.

Introducing ONCOBOARD
If you’re ready to explore the benefits of virtual collaboration platforms, consider ONCOBOARD, Aptitude Health’s collaborative online community platform tool. ONCOBOARD provides a closed online community of selected oncology or hematology experts. Members can instantly ask questions to medical specialists and get their professional input. Feedback is swiftly captured in state-of-the-art insights reports.

With ONCOBOARD, your team members have 24/7 access to up-to-date information and experienced healthcare providers.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.